Arkolith/Insider Trading/BIIB/Form 4

Alexander Susan H

EVP Chief Legal OfficerBIOGEN INC. (BIIB) · full profile →Form 4 · filed Feb 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Option exercise(M)5K—$043K
Feb 6, 2026Tax withholding(F)2K$201.18$305K42K
Feb 6, 2026Tax withholding(F)931$201.18$187K38K
Feb 6, 2026Option exercise(M)2K—$039K
Feb 6, 2026Tax withholding(F)1K$201.18$213K37K
Feb 6, 2026Option exercise(M)2K—$038K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2026Option exercise(M)5K—$010K
Feb 6, 2026Option exercise(M)2K—$02K
Feb 6, 2026Option exercise(M)2K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875045-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BIOGEN INC.

Build

Ask your agent about BIIB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000875045-26-000015"
Ask your agent
Use Arkolith to summarize insider buying and selling at BIOGEN INC.
over the last 90 days and cite the filings.